Overview

Update
Status
Acquired by on June 17, 2015
IPO / Stock
Went Public on Oct 11, 2012 / NASDAQ:KYTH
Headquarters:
Calabasas, CA
Description:
Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
Founders:
,
Categories:
Biopharma, Health Care, Biotechnology
Website:
http://www.kytherabiopharma.com
Social:

Company Details

Update

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.

KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.

Funding Rounds (4) - $98.4M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2011$37.4M / Series D8
May, 2008$30M / Series C8
Jul, 2006$30M / Series B6
Sep, 2005$1M / Seed1

Current Team (18)

Update

Offices/Locations (1)

Update
  • Headquarters

    27200 West Agoura Road

    Suite 200

    Calabasas, CA 91301

    USA

Past Team (6)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos